After its founding in 1976, scientists at Genentech worked methodically toward the development of its first biotechnology product. It was nearly a decade later that the FDA approved Protropin, a ...

Inflation and the Covid-19 pandemic have put pharmaceutical productivity front and center in recent years. Thus, drug companies are under mounting pressure to prove that new treatments are safe and ...

In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in Preclinical Safety Studies,” outlining its commitment to advancing ...

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, received an up to $21M award to lead a project to develop next-generation models of drug toxicity to advance safer ...

The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than what U.S.

Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...

For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...